Lenard A. Adler, MD

Department of Psychiatry, New York University Grossman School of Medicine, New York, New York

  • 27Articles
  • 111.3KReads
  • 2002–2026Active
  • 77Collaborators
  • 363Citations

About

Lenard A. Adler, MD, is affiliated with the Department of Psychiatry at New York University Grossman School of Medicine in New York. With publications spanning from 2002 to 2026, Adler has contributed to topics including neurodevelopmental disorders, major depressive disorder, addiction, anxiety, and attention-deficit/hyperactivity disorder. Frequent collaborators include Jeffrey H. Newcorn, Richard H. Weisler, Thomas J. Spencer, David Michelson, and Joseph Biederman.

Publications

JCP
Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms
Original Research

Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms

May 27, 2026

Viloxazine ER was well tolerated and associated with improvements in ADHD, depression, and anxiety symptoms in this real-world study.
, , , et al
JCP
Original Research

Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD

June 29, 2021

Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
, , , et al
JCP
Original Research

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study

July 15, 2013

, , , et al
JCP
Original Research

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

December 15, 2012

, , , et al
JCP
Original Research

Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder

July 15, 2012

, , , et al
JCP
Original Research

An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD

January 10, 2012

, , , et al
JCP
Educational Activity

Administering and Evaluating the Results of the Adult ADHD Self-Report Scale (ASRS) in Adolescents

June 15, 2011

,
JCP
Educational Activity

Assessing Adolescents Using ADHD Rating Scales

May 15, 2011

,
JCP
Educational Activity

Performance Improvement CME: Adult ADHD

April 15, 2011

, ,
JCP
Educational Activity

Monitoring Adults With ADHD: A Focus on Executive and Behavioral Function

August 15, 2010

JCP
Original Research

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

May 18, 2010

, , , et al
JCP
Original Research

Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder

December 15, 2009

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe